Trial · NCT03522246
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Arm A: Rucaparib + Nivolumab | 436 | |
| Overall Study | STARTED | Arm B: Rucaparib + Placebo | 427 | |
| Overall Study | STARTED | Arm C: Placebo + Nivolumab | 108 | |
| Overall Study | STARTED | Arm D: Placebo + Placebo | 111 | |
| Overall Study | STARTED | Japanese Open-label Safety Cohort: Rucaparib + Nivolumab | 15 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Arm A: Rucaparib + Nivolumab | 433 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Arm B: Rucaparib + Placebo | 425 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Arm C: Placebo + Nivolumab | 108 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Arm D: Placebo + Placebo | 110 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Japanese Open-label Safety Cohort: Rucaparib + Nivolumab | 15 | |
| Overall Study | Safety Population | Arm A: Rucaparib + Nivolumab | 410 | |
| Overall Study | Safety Population | Arm B: Rucaparib + Placebo | 448 | |
| Overall Study | Safety Population | Arm C: Placebo + Nivolumab | 107 | |
| Overall Study | Safety Population | Arm D: Placebo + Placebo | 111 | |
| Overall Study | Safety Population | Japanese Open-label Safety Cohort: Rucaparib + Nivolumab | 15 | |
| Overall Study | COMPLETED | Arm A: Rucaparib + Nivolumab | 252 | |
| Overall Study | COMPLETED | Arm B: Rucaparib + Placebo | 233 | |
| Overall Study | COMPLETED | Arm C: Placebo + Nivolumab | 62 | |
| Overall Study | COMPLETED | Arm D: Placebo + Placebo | 66 | |
| Overall Study | COMPLETED | Japanese Open-label Safety Cohort: Rucaparib + Nivolumab | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03522246/flow